As of 2023, France’s share of scientific publications in pulmonary and respiratory medicine among the world's top 10% most-cited stood at an unspecified baseline. The forecast for 2024-2028 reflects a gradual increase from 9.98% in 2024 to 10.61% in 2028, indicating a steady upward trend.
Year-on-year variations show consistent growth, with percentage increases hovering around 1.5% annually, reflecting France's strengthening influence in the field. The five-year compound annual growth rate (CAGR) suggests an average yearly increase in the share.
Future trends to watch for:
- Continued investment in R&D could further boost these figures.
- Collaborations on an international scale might influence citation metrics.
- Technological advancements in respiratory medicine research.
